Patents by Inventor Fotios M. Plakogiannis

Fotios M. Plakogiannis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal and/or topical delivery system comprising clobazam
    Patent number: 10624901
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: April 21, 2020
    Assignee: Alpha to Omega Pharmaceutical Consultants, Inc.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi
  • TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEM COMPRISING CLOBAZAM
    Publication number: 20200009154
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 9, 2020
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi
  • Transdermal and/or topical delivery systems composed of doxylamine succinate and pyridoxine hydrochloride in combination, or alone
    Patent number: 10500196
    Abstract: Pharmaceutical compositions for simultaneous transdermal delivery of Doxylamine and Pyridoxine comprising Doxylamine or its salts, Pyridoxine or its salts or its active metabolites and a vehicle system wherein pharmaceutical compositions are liquid formulations, semisolid formulations and polymer matrices. Further pharmaceutical compositions can be incorporated into transdermal delivery systems or transdermal patches. The invention provides a method for treatment of nausea and vomiting in general, and for pregnant women in particular by continuous and simultaneous transdermal delivery of Doxylamine and Pyridoxine. This is to be accomplished through topical application of pharmaceutical compositions or by application of a transdermal delivery system or transdermal patch to the surface of the skin wherein the duration of application is once in a day, once every two days, once every three days, once every four days, once every five days, once every six days, or once in a week.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: December 10, 2019
    Assignee: Alpha To Omega Pharmaceutical Consultants, Inc.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Tamanna Lather, Marina Borovinskaya
  • Transdermal and/or topical delivery system comprising clobazam
    Patent number: 10449201
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: October 22, 2019
    Assignee: ALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS, INC.
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi
  • TRANSDERMAL DELIVERY OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
    Publication number: 20180250281
    Abstract: Pharmaceutical compositions for simultaneous transdermal delivery of Doxylamine and Pyridoxine comprising Doxylamine or its salts, Pyridoxine or its salts or its active metabolites and a vehicle system wherein pharmaceutical compositions are liquid formulations, semisolid formulations and polymer matrices. Further pharmaceutical compositions can be incorporated into transdermal delivery systems or transdermal patches. The invention provides a method for treatment of nausea and vomiting in general, and for pregnant women in particular by continuous and simultaneous transdermal delivery of Doxylamine and Pyridoxine. This is to be accomplished through topical application of pharmaceutical compositions or by application of a transdermal delivery system or transdermal patch to the surface of the skin wherein the duration of application is once in a day, once every two days, once every three days, once every four days, once every five days, once every six days, or once in a week.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 6, 2018
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Tamanna Lather, Marina Borovinskaya
  • Aripiprazole compositions and methods for its transdermal delivery
    Patent number: 9757374
    Abstract: The present invention discloses compositions of liquid and gel formulation containing aripiprazole in the form of a patch for transdermal delivery.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: September 12, 2017
    Assignee: Aequus Pharmaceuticals Inc.
    Inventors: Fotios M. Plakogiannis, Muhammed Anwar Hossain
  • TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEMS COMPOSED OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE IN COMBINATION, OR ALONE
    Publication number: 20170049759
    Abstract: Pharmaceutical compositions for simultaneous transdermal delivery of Doxylamine and Pyridoxine comprising Doxylamine or its salts, Pyridoxine or its salts or its active metabolites and a vehicle system wherein pharmaceutical compositions are liquid formulations, semisolid formulations and polymer matrices. Further pharmaceutical compositions can be incorporated into transdermal delivery systems or transdermal patches. The invention provides a method for treatment of nausea and vomiting in general, and for pregnant women in particular by continuous and simultaneous transdermal delivery of Doxylamine and Pyridoxine. This is to be accomplished through topical application of pharmaceutical compositions or by application of a transdermal delivery system or transdermal patch to the surface of the skin wherein the duration of application is once in a day, once every two days, once every three days, once every four days, once every five days, once every six days, or once in a week.
    Type: Application
    Filed: August 4, 2016
    Publication date: February 23, 2017
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Tamanna Lather, Marina Borovinskaya
  • TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEM COMPRISING CLOBAZAM
    Publication number: 20170049714
    Abstract: A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
    Type: Application
    Filed: July 28, 2016
    Publication date: February 23, 2017
    Inventors: Fotios M. Plakogiannis, Donald McAfee, Nisarg Modi
  • ARIPIPRAZOLE COMPOSITIONS AND METHODS FOR ITS TRANSDERMAL DELIVERY
    Publication number: 20150342949
    Abstract: The present invention discloses compositions of liquid and gel formulation containing aripiprazole in the form of a patch for transdermal delivery.
    Type: Application
    Filed: August 13, 2015
    Publication date: December 3, 2015
    Inventors: Fotios M. PLAKOGIANNIS, Muhammed Anwar HOSSAIN
  • Aripiprazole compositions and methods for its transdermal delivery
    Patent number: 9138402
    Abstract: The present invention discloses compositions of liquid and gel formulation containing aripiprazole in the form of a patch for transdermal delivery.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: September 22, 2015
    Assignee: Transdermal Research Pharm Laboratories, LLC
    Inventors: Fotios M. Plakogiannis, Muhammed Anwar Hossain
  • ARIPIPRAZOLE COMPOSITIONS AND METHODS FOR ITS TRANSDERMAL DELIVERY
    Publication number: 20130209552
    Abstract: The present invention discloses compositions of liquid and gel formulation containing aripiprazole in the form of a patch for transdermal delivery.
    Type: Application
    Filed: October 20, 2011
    Publication date: August 15, 2013
    Applicant: TRANSDERMAL RESEARCH PHARM LABORATORIES, LLC
    Inventors: Fotios M. Plakogiannis, Muhammed Anwar Hossain
  • ARIPIPRAZOLE COMPOSITIONS AND METHODS FOR ITS TRANSDERMAL DELIVERY
    Publication number: 20130171237
    Abstract: The present invention discloses compositions of liquid and gel formulation containing aripiprazole in the form of a patch for transdermal delivery.
    Type: Application
    Filed: November 5, 2012
    Publication date: July 4, 2013
    Inventors: Fotios M. Plakogiannis, Anwar Muhammed Hossain